Literature DB >> 16556688

Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies.

Andrew R Macrae1, Peter A Kavsak, Viliam Lustig, Rakesh Bhargava, Rudy Vandersluis, Glenn E Palomaki, Marie-Jeanne Yerna, Allan S Jaffe.   

Abstract

BACKGROUND: The American Heart Association (AHA) case definition for acute myocardial infarction (AMI) requires an "adequate set" of biomarkers: 2 measurements of the same marker at least 6 h apart. A sensitive troponin assay might detect significant changes in concentration earlier. We determined AMI prevalence, using protocols with shorter intervals between measurements, with and without incorporating the time from onset of symptoms.
METHODS: The AHA case definition was used to retrospectively assign a diagnosis in 258 patients presenting to the emergency department with symptoms of cardiac ischemia. AMI was diagnosed if either specimen in an adequate set had a cardiac troponin I (cTnI) above the 99th percentile (AccuTnI >0.04 microg/L; Beckman Coulter) with a > or =20% change in concentration between specimens. We assessed positivity for AMI after progressively decreasing the time interval between specimens in specimen sets. In addition, for each patient, 2 additional specimen pairs were selected: pairs collected at least 1 h apart with 1 specimen being either > or =3 h after onset or > or =6 h after onset.
RESULTS: When we used the AHA definition, the AMI prevalence was 35.7%. Prevalence was not significantly diminished when the interval between specimens was > or =5, > or =4, or > or= 3 h (36.4%, 34.5%, and 33.7%, respectively) compared with the AHA > or =6 h interval. When the time from onset of symptoms was included in the specimen selection algorithm, a 1-h interval was sufficient provided that at least one specimen was collected > or =6 h after onset (prevalence, 34.1%; P = 0.48 vs AHA definition).
CONCLUSION: A sensitive cTnI assay in specimen sets with time intervals > or =3 h, or having one specimen > or =6 h after onset, gave an AMI prevalence equivalent to the AHA definition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16556688     DOI: 10.1373/clinchem.2005.059550

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  26 in total

1.  "Upstream markers" provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes.

Authors:  Peter A Kavsak; Dennis T Ko; Alice M Newman; Glenn E Palomaki; Viliam Lustig; Andrew R Macrae; Allan S Jaffe
Journal:  Clin Chim Acta       Date:  2007-10-03       Impact factor: 3.786

Review 2.  The evolving role of cardiac troponin in the evaluation of cardiac disorders.

Authors:  Paul Anaya; David J Moliterno
Journal:  Curr Cardiol Rep       Date:  2013-11       Impact factor: 2.931

Review 3.  Chest pain triage: Current trends in the emergency departments in the United States.

Authors:  Matthew C DeLaney; Matthew Neth; Jared J Thomas
Journal:  J Nucl Cardiol       Date:  2016-09-08       Impact factor: 5.952

Review 4.  Identification of myocardial injury in the emergency setting.

Authors:  Peter A Kavsak; Andrew Worster; John J You; Mark Oremus; Adell Elsharif; Stephen A Hill; P J Devereaux; Andrew R MacRae; Allan S Jaffe
Journal:  Clin Biochem       Date:  2009-12-21       Impact factor: 3.281

Review 5.  Effectiveness of practices for improving the diagnostic accuracy of Non ST Elevation Myocardial Infarction in the Emergency Department: A Laboratory Medicine Best Practices™ systematic review.

Authors:  Christopher Layfield; John Rose; Aaron Alford; Susan R Snyder; Fred S Apple; Farah M Chowdhury; Michael C Kontos; L Kristin Newby; Alan B Storrow; Milenko Tanasijevic; Elizabeth Leibach; Edward B Liebow; Robert H Christenson
Journal:  Clin Biochem       Date:  2015-02-07       Impact factor: 3.281

6.  Identifying patients for early discharge: performance of decision rules among patients with acute chest pain.

Authors:  Simon A Mahler; Chadwick D Miller; Judd E Hollander; John T Nagurney; Robert Birkhahn; Adam J Singer; Nathan I Shapiro; Ted Glynn; Richard Nowak; Basmah Safdar; Mary Peberdy; Francis L Counselman; Abhinav Chandra; Joshua Kosowsky; James Neuenschwander; Jon W Schrock; Stephen Plantholt; Deborah B Diercks; W Frank Peacock
Journal:  Int J Cardiol       Date:  2012-10-30       Impact factor: 4.164

Review 7.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White
Journal:  Nat Rev Cardiol       Date:  2012-08-25       Impact factor: 32.419

8.  Prognostic value of cardiac troponin T after myocardial infarction: a contemporary community experience.

Authors:  Yariv Gerber; Allan S Jaffe; Susan A Weston; Ruoxiang Jiang; Véronique L Roger
Journal:  Mayo Clin Proc       Date:  2012-03       Impact factor: 7.616

Review 9.  High-Sensitivity Cardiac Troponin for the Diagnosis of Patients with Acute Coronary Syndromes.

Authors:  Vlad C Vasile; Allan S Jaffe
Journal:  Curr Cardiol Rep       Date:  2017-08-24       Impact factor: 2.931

10.  [Essential cardiac biomarkers in myocardial infarction and heart failure].

Authors:  M Mueller; E Giannitsis; H A Katus
Journal:  Herz       Date:  2014-09       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.